Promises and Perils of Prescription Drug Monitoring Programs
Health in Justice Action Lab Workshop
As a go-to response to the ongoing overdose crisis, many US jurisdictions have adopted new--or expanded existing--prescription drug monitoring programs (PDMPs). The scale-up in the number, scope, funding, and legal mandates of these systems has occurred rapidly and without much scrutiny from empirical and theoretical perspectives.
To address this gap, the workshop Promises and Perils of Prescription Drug Monitoring Programs offered a survey of interdisciplinary research on PDMPs; explored current advocacy and reform efforts; and articulated strategies to maximize the benefit of PDMPs, while minimizing possible harms. Topics included privacy, algorithmic fairness, decision support functionality, and the PDMPs role in facilitating care coordination and provider-patient communication.